Tools
ToolsDoble, Brett, Langdon, Peter E., Shepstone, Lee, Murphy, Glynis H., Fowler, David, Heavens, David, Malovic, Aida, Russell, Alexandra, Rose, Alice, Mullineaux, Louise and Wilson, Edward C. F. (2017) Economic evaluation alongside a randomized controlled crossover trial of modified group cognitive–behavioral therapy for anxiety compared to treatment-as-usual in adults with Asperger syndrome. MDM Policy and Practice, 2 (2). ISSN 2381-4683
Preview |
PDF (doble-et-al-2017-economic-evaluation-alongside-a-randomized-controlled-crossover-trial-of-modified-group-cognitive)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (575kB) | Preview |
Abstract
Background: There is a growing interest in using group cognitive–behavioral therapy (CBT) with people who have Asperger syndrome (AS) and comorbid mental health problems. This study aims to assess the cost-effectiveness of modified group CBT for adults with AS experiencing co-occurring anxiety compared to treatment-as-usual. Methods: Economic evaluation alongside a pilot, multicenter, single-blind, randomized controlled crossover trial. Costs from the UK public sector (National Health Service and Social Services) and societal perspectives, quality-adjusted life years (QALYs), incremental net (monetary) benefit (INB), expected value of perfect information, expected value of sample information, expected net gain of sampling, and efficient sample size of a future trial are reported. Results: Over 48 weeks, from the societal perspective, CBT results in additional costs of £6,647, with only a 0.015 incremental gain in QALYs, leading to a negative INB estimate of £6,206 and a 23% probability of cost-effectiveness at a threshold of £30,000/QALY. Results from sensitivity analyses support the unlikely cost-effectiveness of CBT but indicate the potential for cost-effectiveness over longer time horizons. Eliminating decision uncertainty is valued at £277 million, and the efficient sample size for a future trial is estimated at 1,200 participants per arm. Limitations: Relatively small sample size and prevalence of missing data present challenges to the interpretation of the results. Conclusions: Current evidence from this small pilot study suggests that, on average, modified group CBT is not cost-effective. However, there is much decision uncertainty so such a conclusion could be wrong. A large, full-scale trial to reduce uncertainty would be an efficient investment for the UK health economy.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | autism spectrum disorder,cost-effectiveness analysis,psychiatric disorders,value of information,health policy,public health, environmental and occupational health,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2719 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Social Sciences > School of Psychology |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Population Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 07 Oct 2023 01:26 |
| Last Modified: | 06 Feb 2025 11:38 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/93183 |
| DOI: | 10.1177/2381468317729353 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |